Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room

作者: Simon Eckermann , Brita Pekarsky

DOI: 10.1007/S40273-014-0140-3

关键词: Straw manEconomicsMicroeconomicsReimbursementShadow priceAllocative efficiencyOpportunity costWelfare economicsAlternative strategyHealthcare systemCost–benefit analysis

摘要: In current literature, displaced services have been suggested to provide a basis for determining threshold value the effects of new technology as part reimbursement process when budgets are fixed. We critically examine conditions under which would represent an economically meaningful value. first show that if we assume least cost-effective finance technology, then incremental cost-effectiveness ratio (ICER) (d) only coincides with related opportunity cost adopting ICER most service in expansion (n), highly restrictive conditions—namely, complete allocative efficiency existing provision health care interventions. More generally, fixed budget comprises two actions; adoption and financing through displacement effect is net these actions. order be pathway within budget, strategy compared alternative reimbursement: optimal reallocation, gain maximizing financed by loss minimizing contraction. The shadow price \( \beta_{c} = \left( {\frac{1}{n} + \frac{1}{d} - \frac{1}{m}} \right)^{ 1} , \) accounts both imperfect (the service, d < m, contraction) inefficiency (n m) characteristic systems.

参考文章(27)
Karl Claxton, Steve Martin, Marta Soares, Nigel Rice, Eldon Spackman, Sebastian Hinde, Nancy Devlin, Peter C Smith, Mark Sculpher, Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold Health Technology Assessment. ,vol. 19, pp. 1- 504 ,(2015) , 10.3310/HTA19140
Jonathan Karnon, Orla Caffrey, Clarabelle Pham, Richard Grieve, David Ben-Tovim, Paul Hakendorf, Maria Crotty, APPLYING RISK ADJUSTED COST‐EFFECTIVENESS (RAC‐E) ANALYSIS TO HOSPITALS: ESTIMATING THE COSTS AND CONSEQUENCES OF VARIATION IN CLINICAL PRACTICE Health Economics. ,vol. 22, pp. 631- 642 ,(2013) , 10.1002/HEC.2828
Stephen Birch, Amiram Gafni, Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? Journal of Health Economics. ,vol. 11, pp. 279- 296 ,(1992) , 10.1016/0167-6296(92)90004-K
Danny A. Ruta, Cam Donaldson, Ingrid Gilray, Economics, Public Health and Health Care Purchasing: The Tayside Experience of Programme Budgeting and Marginal Analysis Journal of Health Services Research & Policy. ,vol. 1, pp. 185- 193 ,(1996) , 10.1177/135581969600100402
Simon Eckermann, Andrew R. Willan, Expected value of information and decision making in HTA Health Economics. ,vol. 16, pp. 195- 209 ,(2007) , 10.1002/HEC.1161
Karl Claxton, Andrew Briggs, Martin J Buxton, Anthony J Culyer, Christopher McCabe, Simon Walker, Mark J Sculpher, Value based pricing for NHS drugs: an opportunity not to be missed? BMJ. ,vol. 336, pp. 251- 254 ,(2008) , 10.1136/BMJ.39434.500185.25
Simon Eckermann, Jon Karnon, Andrew R. Willan, The value of value of information: best informing research design and prioritization using current methods. PharmacoEconomics. ,vol. 28, pp. 699- 709 ,(2010) , 10.2165/11537370-000000000-00000
Simon Eckermann, Michael Coory, Andrew R. Willan, Consistently Estimating Absolute Risk Difference when Translating Evidence to Jurisdictions of Interest PharmacoEconomics. ,vol. 29, pp. 87- 96 ,(2011) , 10.2165/11585910-000000000-00000
Simon Eckermann, Andrew R. Willan, The option value of delay in health technology assessment. Medical Decision Making. ,vol. 28, pp. 300- 305 ,(2008) , 10.1177/0272989X07312477
Gavin Mooney, Jo Coast, Steven Jan, Mandy Ryan, Virginia Wiseman, , Searching for a threshold – Not so NICE… Journal of Health Services Research & Policy. ,vol. 12, pp. 190- 190 ,(2007) , 10.1258/135581907781543058